ArticleAlzheimer's & dementia (Amsterdam, Netherlands)2019
Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study.
Sid E O'Bryant et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papertrialcites it